The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria
- PMID: 18808723
- PMCID: PMC2569040
- DOI: 10.1186/1471-230X-8-43
The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria
Abstract
Background: Epidemiological studies suggest considerable overlap between functional dyspepsia (FD) and irritable bowel syndrome (IBS). To date, no surveys have been performed to investigate the clinical overlap between these two disorders using Rome III criteria. Our aim was to investigate the prevalence and risk factors for the overlap of FD and IBS based on Rome III criteria in a large clinical sample.
Methods: Consecutive patients at the general gastroenterology outpatient clinic were requested to complete a self-report questionnaire. FD and IBS were defined by Rome III criteria.
Results: Questionnaires were returned by 3014 patients (52.8% female, 89% response rate). FD-IBS overlap was observed in 5.0% of the patients, while 15.2% and 10.9% of the patients were classified as FD alone and IBS alone, respectively. Compared with non-IBS patients, the odds ratio of having FD among IBS patients was 2.09 (95% CI: 1.68-2.59). Patients with FD-IBS overlap had higher severity scores for the postprandial fullness symptom (2.35 +/- 1.49 vs. 1.72 +/- 1.59, P < 0.001) and overall FD symptom (6.65 +/- 2.88 vs. 5.82 +/- 2.76, P = 0.002) than those with FD alone. The only independent risk factor for FD-IBS overlap vs. FD alone was the presence of postprandial fullness symptom (OR 2.67, 95% CI: 1.34-5.31).
Conclusion: Clinical overlap of FD and IBS according to Rome III criteria is very common. One risk factor for FD-IBS overlap is the presence of postprandial fullness symptom. This study provides clues for future pathophysiological studies of FD and IBS.
Figures
Similar articles
-
Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.Am J Gastroenterol. 2004 Jun;99(6):1152-9. doi: 10.1111/j.1572-0241.2004.30040.x. Am J Gastroenterol. 2004. PMID: 15180740
-
Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.Scand J Gastroenterol. 2007 Aug;42(8):951-6. doi: 10.1080/00365520701204204. Scand J Gastroenterol. 2007. PMID: 17613924
-
Functional dyspepsia and irritable bowel syndrome in patients with achalasia and its association with non-cardiac chest pain and a decreased health-related quality of life.Scand J Gastroenterol. 2009;44(6):687-91. doi: 10.1080/00365520902783709. Scand J Gastroenterol. 2009. PMID: 19263270
-
A unifying hypothesis for the functional gastrointestinal disorders: really multiple diseases or one irritable gut?Rev Gastroenterol Disord. 2006 Spring;6(2):72-8. Rev Gastroenterol Disord. 2006. PMID: 16699476 Review.
-
Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.Acta Pol Pharm. 2009 Sep-Oct;66(5):447-60. Acta Pol Pharm. 2009. PMID: 19894640 Review.
Cited by
-
Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope?Clin Interv Aging. 2016 Nov 11;11:1601-1608. doi: 10.2147/CIA.S106284. eCollection 2016. Clin Interv Aging. 2016. PMID: 27956826 Free PMC article. Clinical Trial.
-
Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria.Nat Rev Gastroenterol Hepatol. 2013 Mar;10(3):134-41. doi: 10.1038/nrgastro.2013.14. Epub 2013 Feb 12. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23399526 Review.
-
Prevalence and trigger factors of functional gastrointestinal disorders among male civil pilots in China.Sci Rep. 2021 Jan 21;11(1):2021. doi: 10.1038/s41598-021-81825-0. Sci Rep. 2021. PMID: 33479463 Free PMC article.
-
Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.Can J Gastroenterol. 2011 Jul;25(7):377-83. doi: 10.1155/2011/953975. Can J Gastroenterol. 2011. PMID: 21876860 Free PMC article. Review.
-
Overlap of 'disorders of gut-brain interaction' and their impact on quality of life and somatization in a tertiary care center- A cross-sectional study.Indian J Gastroenterol. 2025 Aug;44(4):478-488. doi: 10.1007/s12664-025-01770-y. Epub 2025 Apr 15. Indian J Gastroenterol. 2025. PMID: 40232666
References
-
- Chen MH, Zhong BH, Li CJ, Peng XZ, Hu PJ. An epidemiological study on dyspepsia in Guangdong area. Chin J Intern Med. 1998;37:312–314.
-
- Wang JL. Clinical epidemiology. 2. Shanghai Science & Technology Press; 2001.
-
- Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, et al. The functional gastrointestinal disorders. 3. Washington: Degnon; 2006.
-
- Alizadeh-Naeeni M, Saberi-Firoozi M, Pourkhajeh A, Taheri H, Malekzadeh R, Derakhshan MH, Massarrat S, Iranian Functional Dyspepsia Study Group Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study. Digestion. 2002;66:92–98. doi: 10.1159/000065589. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical